Subject(s)

Dermatologic Agents/administration & dosage , Dermatologic Agents/adverse effects , Education , Fumarates/administration & dosage , Fumarates/adverse effects , Psoriasis/drug therapy , Administration, Oral , Alopecia Areata/drug therapy , Alopecia Areata/epidemiology , Alopecia Areata/psychology , Autoimmune Diseases/drug therapy , Autoimmune Diseases/epidemiology , Autoimmune Diseases/psychology , Biological Availability , Clinical Trials as Topic , Comorbidity , Dermatologic Agents/pharmacokinetics , Dimethyl Fumarate , Dose-Response Relationship, Drug , Drug Administration Schedule , Etanercept , Follow-Up Studies , Fumarates/pharmacokinetics , Humans , Immunoglobulin G/administration & dosage , Immunoglobulin G/adverse effects , Metabolic Clearance Rate/physiology , PUVA Therapy/methods , Pilot Projects , Prospective Studies , Psoriasis/epidemiology , Psoriasis/psychology , Quality of Life , Receptors, Tumor Necrosis Factor/administration & dosage , Registries , Sick Role